Aggregator

CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences

1 month ago

CMS’s proposed expansion of Medicare TAVR coverage to include select asymptomatic severe aortic stenosis patients and reduce access barriers for symptomatic patients could significantly increase TAVR adoption, creating a growth opportunity for Edwards Lifesciences through expanded eligibility, higher procedure volumes, and continued leadership in structural heart care.

The post CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences appeared first on MedTech Intelligence.

Rich West

Setchu Spring 2027: In the Net

1 month ago

Satoshi Kuwata turned up the experimentation a notch to make his favorite things — and one he despises — converge in this crafty collection.

Sandra Salibian